Construction_NN
and_CC
biological_JJ
characterization_NN
of_IN
an_DT
interleukin-12_NN
fusion_NN
protein_NN
-LRB-_-LRB-
Flexi-12_NN
-RRB-_-RRB-
:_:
delivery_NN
to_TO
acute_JJ
myeloid_JJ
leukemic_JJ
blasts_NNS
using_VBG
adeno-associated_JJ
virus_NN
._.

Interleukin-12_NN
-LRB-_-LRB-
IL-12_NN
-RRB-_-RRB-
is_VBZ
a_DT
cytokine_NN
that_WDT
exhibits_VBZ
pleiotropic_JJ
effects_NNS
on_IN
lymphocytes_NNS
and_CC
natural_JJ
killer_NN
cells_NNS
and_CC
has_VBZ
been_VBN
shown_VBN
to_TO
have_VB
promise_NN
for_IN
the_DT
immunotherapy_NN
of_IN
cancer_NN
._.

The_DT
combination_NN
of_IN
the_DT
immune_JJ
costimulatory_JJ
molecule_NN
B7_NN
.1_CD
and_CC
IL-12_NN
has_VBZ
been_VBN
shown_VBN
to_TO
be_VB
synergistic_JJ
for_IN
T_NN
cell_NN
activation_NN
._.

By_IN
transfecting_VBG
tumor_NN
cells_NNS
with_IN
both_CC
IL-12_NN
and_CC
B7_NN
.1_CD
cDNAs_NNS
,_,
it_PRP
may_MD
be_VB
possible_JJ
to_TO
use_VB
these_DT
modified_VBN
targets_NNS
as_IN
vaccines_NNS
._.

A_DT
major_JJ
obstacle_NN
in_IN
designing_VBG
a_DT
vector_NN
to_TO
deliver_VB
these_DT
genes_NNS
results_VBZ
from_IN
the_DT
structure_NN
of_IN
IL-12_NN
._.

Functional_JJ
IL-12_NN
is_VBZ
a_DT
heterodimer_NN
composed_VBN
of_IN
two_CD
distinct_JJ
subunits_NNS
that_WDT
are_VBP
encoded_VBN
by_IN
separate_JJ
genes_NNS
on_IN
different_JJ
chromosomes_NNS
._.

Production_NN
of_IN
functional_JJ
IL-12_NN
requires_VBZ
the_DT
coordinated_VBN
expression_NN
of_IN
both_DT
genes_NNS
._.

This_DT
presents_VBZ
several_JJ
problems_NNS
in_IN
vectors_NNS
,_,
particularly_RB
those_DT
in_IN
which_WDT
additional_JJ
genes_NNS
,_,
either_CC
a_DT
co-stimulatory_JJ
gene_NN
or_CC
a_DT
selectable_JJ
marker_NN
,_,
are_VBP
inserted_VBN
._.

Therefore_RB
,_,
we_PRP
have_VBP
constructed_VBN
a_DT
single_JJ
cDNA_NN
that_WDT
encodes_VBZ
a_DT
single-chain_JJ
protein_NN
,_,
called_VBN
Flexi-12_NN
,_,
which_WDT
retains_VBZ
all_DT
of_IN
the_DT
biological_JJ
characteristics_NNS
of_IN
recombinant_JJ
IL-12_NN
-LRB-_-LRB-
rIL-12_NN
-RRB-_-RRB-
._.

The_DT
monomeric_JJ
polypeptide_NN
Flexi-12_NN
is_VBZ
able_JJ
to_TO
induce_VB
the_DT
proliferation_NN
of_IN
phytohemagglutinin_NN
-LRB-_-LRB-
PHA_NN
-RRB-_-RRB-
blasts_NNS
,_,
induce_VB
PHA_NN
blasts_NNS
to_TO
secrete_VB
interferon-gamma_NN
-LRB-_-LRB-
IFN-gamma_NN
-RRB-_-RRB-
and_CC
additionally_RB
,_,
by_IN
preincubation_NN
,_,
enhance_VB
the_DT
killing_NN
of_IN
K562_NN
targets_NNS
by_IN
PBLs_NNS
._.

These_DT
phenomena_NNS
are_VBP
in_IN
a_DT
dose-dependent_JJ
manner_NN
comparable_JJ
to_TO
that_DT
seen_VBN
with_IN
rIL-12_NN
._.

We_PRP
have_VBP
also_RB
shown_VBN
that_IN
tyrosine_NN
phosphorylation_NN
of_IN
the_DT
STAT_NN
4_CD
transcription_NN
factor_NN
,_,
which_WDT
has_VBZ
been_VBN
shown_VBN
to_TO
be_VB
unique_JJ
to_TO
the_DT
IL-12_NN
signaling_NN
pathway_NN
,_,
occurs_VBZ
with_IN
Flexi-12_NN
at_IN
levels_NNS
similar_JJ
to_TO
those_DT
seen_VBN
with_IN
rIL-12_NN
._.

We_PRP
have_VBP
packaged_VBN
Flexi-12_NN
into_IN
a_DT
recombinant_JJ
adeno-associated_JJ
virus_NN
-LRB-_-LRB-
AAV_NN
-RRB-_-RRB-
and_CC
used_VBN
this_DT
vector_NN
to_TO
infect_VB
acute_JJ
myeloid_JJ
leukemic_JJ
-LRB-_-LRB-
AML_NN
-RRB-_-RRB-
blasts_NNS
._.

Infected_JJ
AML_NN
blasts_NNS
produced_VBD
between_IN
2_CD
and_CC
6_CD
ng_NN
of_IN
IL-12_NN
\/_:
10_CD
-LRB-_-LRB-
6_CD
-RRB-_-RRB-
cells_NNS
per_IN
ml_NN
per_IN
48_CD
hr_NN
._.

These_DT
studies_NNS
also_RB
confirm_VBP
that_IN
AAV_NN
is_VBZ
an_DT
efficient_JJ
delivery_NN
vehicle_NN
for_IN
cytokines_NNS
to_TO
leukemic_JJ
cells_NNS
._.

Direct_JJ
analysis_NN
of_IN
these_DT
modified_VBN
cells_NNS
acting_VBG
as_IN
tumor_NN
vaccines_NNS
is_VBZ
underway_JJ
._.

